公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
2014 | Effect of false lumen partial thrombosis on repaired acute type A aortic dissection. | Tsai, MT; Wu, HY; Roan, JN; Tsai, YS; Hsieh, PC ; Yang, YJ; Luo, CY | The Journal of thoracic and cardiovascular surgery 148(5), 2140-2146.e3 | | | |
2021 | Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation | Lundy, DJ; Nguyễn, H; Hsieh, PC | Pharmaceutics 13(8), 1193 | | | |
2023 | ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin trafficking | Chiu, CH; Hsuan, CF; Lin, SH; Hung, YJ; Hwu, CM; Hee, SW; Lin, SW; Fong, SW; Hsieh, PC ; Yang, WS; Lin, WC; Lee, HL; Hsieh, ML; Li, WY; Lin, JW; Hsu, CN; Wu, VC; Chuang, GT; Chang, YC ; Chuang, LM | Journal of biomedical science 30(1), 13 | | | |
2021 | Evidence that gut microbiota impacts cardiac extracellular matrix organization after pressure overload. | Chen-Ju Lin; Yu-Che Cheng; Hung-Chih Chen; Yu-Kai Chao; Patrick C Hsieh | | | | |
2017 | Fenugreek Compound (N55) Lowers Plasma Glucose through the Enhancement of Response of Physiological Glucagon-like peptide-1. | Chou, IW; Cheng, YH; Chen, YR ; Hsieh, PC ; King, K | Scientific reports 7(1), 12265 | | | |
2010 | Fibroblast growth factor-10 promotes cardiomyocyte differentiation from embryonic and induced pluripotent stem cells. | Chan, SS; Li, HJ; Hsueh, YC; Lee, DS; Chen, JH; Hwang, SM; Chen, CY; Shih, E; Hsieh, PC | PloS one 5(12), e14414 | | | |
2013 | Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. | Chang, MY; Yang, YJ; Chang, CH; Tang, AC; Liao, WY; Cheng, FY; Yeh, CS; Lai, JJ; Stayton, PS; Hsieh, PC | Journal of controlled release : official journal of the Controlled Release Society 170(2), 287-294 | | | |
2018 | Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant | Cheng, YC; Huang, CY; Ho, MC; Hsu, YH; Syu, SH; Lu, HE; Lin, HI; Lin, CH; Hsieh, PC | Stem Cell Research 28, 1-5 | | | |
2020 | Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9 | Liu, CL; Huang, CY; Chen, HC; Lu, HE; Hsieh, PC ; Lee, JJ | Stem Cell Research 45, 101784 | | | |
2020 | Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene | Lin, HY; TsaiLK; Cheng, YC; Lu, HE; Huang, CY; Hsieh, PC ; Lin, CH | Stem Cell Research 44, 101734 | | | |
2017 | Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene | Hsu, YH; Wu, YT; Huang, CY; Ho, MC; Cheng, YC; Syu, SH; Lu, HE; Chen, YC; Tsai, CL; Lin, HC; Wei, YH; Hsu, YC; Hsieh, PC | Stem Cell Research 25, 245-249 | | | |
2017 | Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2 | Ho, MC; Huang, CY; Lee, JJ; Hsu, SH; Cheng, YC; Hsu, YH; Hwang, DY; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 25, 38-41 | | | |
2021 | Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation | Chiu, YT; Tsai, MH; Chan, DZ; Ko, HW; Lu, HE; Huang, CF; Lin, YJ; Chang, SL; Lo, LW; Huang, CY; Hu, YF; Hsieh, PCH ; Chen, SA | Stem Cell Research 54, 102419 | | | |
2021 | Generation of IBMS-iPSC-021, -022, -023 human induced pluripotent stem cells (IBMSi016-A, IBMSi017-A, and IBMSi018-A) derived from patients with the ALDH2 rs671 polymorphism | Tsai, MH; Chiu, YT; Chan, DZ; Wen, CH; Syu, SH; Lu, HE; Huang, CF; Lin, YJ; Chang, SL; Lo, LW; Huang, CY; Hu, YF; Hsieh, PCH ; Chen, SA | Stem Cell Research 54, 102416 | | | |
2019 | Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation | Lin, HI; Cheng, YC; Ko, HW; Wen, CH; Lu, HE; Huang, CY; Hsieh, PC ; Lin, CH | Stem Cell Research 37, 101447 | | | |
2017 | Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1 | Huang, CY; Ho, MC; Lee, JJ; Hwang, DY; Ko, HW; Cheng, YC; Hsu, YH; Lu, HE; Chen, HC; Hsieh, PC | Stem Cell Research 24, 139-143 | | | |
2021 | Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534 + 1G > T mutation | Ting, CY; Huang, CY; Chen, HC; Chiu, YW; Hsieh, PC ; Lee, JJ | Stem Cell Research 55, 102480 | | | |
2017 | Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation | Lin, CH; Cheng, YC; Lin, HI; Ho, MC; Hsu, YH; Wen, CH; Ko, HW; Lu, HE; Huang, CY; Hsieh, PC | Stem Cell Research 25, 123-127 | | | |
2017 | Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3 | Soong, BW; Syu, SH; Wen, CH; Ko, HW; Wu, ML; Hsieh, PC ; Hwang, SM; Lu, HE | Stem Cell Research 18, 29-32 | | | |
2018 | Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation | Liu, SP; Hsu, YH; Huang, CY; Ho, MC; Cheng, YC; Wen, CH; Lu, HE; Tsai, CH; Shyu, WC; Hsieh, PC | Stem Cell Research 28, 39-43 | | | |